Recent studies linked ATP6AP2 up-regulation to the progression of glioma and colorectal cancer, due to its roles in aberrant activation of the Wnt/beta-catenin signalling pathway [61, 62]. Here, ATP6AP2 is linked to central nervous system cancer.